Verastem (VSTM) Interest & Investment Income (2012 - 2026)
Verastem (VSTM) recorded quarterly Interest & Investment Income of $1.3 million in Q1 2026, up 17.48% quarter-over-quarter from $1.1 million in Q4 2025, and up 35.1% on a YoY basis from $960000.0 in Q1 2025.
Verastem (VSTM) Interest & Investment Income (2012 - 2026) Analysis & Trends
Verastem's Interest & Investment Income history runs 15 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 35.1% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $4.4 million (up 17.72% YoY), while the FY2025 annual figure was $4.1 million, down 1.95% from the prior year.
- Interest & Investment Income was $1.3 million for Q1 2026 at Verastem, up from $1.1 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.2 million in Q3 2023 to a low of $46000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $996647.1 across 5 years, with a median of $976000.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income soared 2021.74% in 2023, then slumped 63.02% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $769000.0 in 2022, then jumped by 143.04% to $1.9 million in 2023, then slumped by 48.21% to $968000.0 in 2024, then advanced by 14.05% to $1.1 million in 2025, then gained by 17.48% to $1.3 million in 2026.
- The last three Interest & Investment Income figures came in at $1.3 million (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 822,000.00 |
| Mar 31, 2025 | 960,000.00 |
| Dec 31, 2024 | 968,000.00 |
| Sep 30, 2024 | 831,000.00 |
| Jun 30, 2024 | 983,000.00 |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 976,000.00 |
| Dec 31, 2022 | 769,000.00 |
| Sep 30, 2022 | 316,000.00 |
| Jun 30, 2022 | 84,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 49,000.00 |